Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Small Cell Lung Carcinoma 1Retinoblastoma 1Retinal Neoplasms 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Cancer Recurrent 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 7Pemetrexed 6osimertinib 5Drug Therapy 5aflutinib 4tislelizumab 3anlotinib 3Radiotherapy 3Radiosurgery 3Paclitaxel 3Cisplatin 3toripalimab 2pembrolizumab 2camrelizumab 2apatinib 2Surgical Procedures, Operative 2S 1 (combination) 2HM781-36B 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2trilaciclib 1surufatinib 1sintilimab 1rezivertinib 1lenvatinib 1icotinib 1famitinib 1envafolimab 1dacomitinib 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × NSCLC × Platinum Compounds × Clear all
NCT07358689 2026-01-22

Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
120 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡